Category Archives: Strategy

Europe and Canada Welcome Trade Agreement Text

The European Federation of Pharmaceutical Industries and Associations (EFPIA) and Canada’s Research-Based Pharmaceutical Companies (Rx&D) have welcome finalization of the text for the Comprehensive Economic and Trade Agreement (CETA). CETA represents the first free trade agreement between any G8 country. EFPIA and Rx&D believe it will, once in place, be beneficial to patients on both […]
Also posted in Europe, Global | Tagged , , | Leave a comment

Email Marketing's Growing Maturity

Email marketing is still very much with us, despite much talk of its demise. But, writes Peter Houston, it has moved on from its “spammy” adolescence. Scary tales of The-Next-Big-Social-Thing killing off the first digital marketing blockbuster have been building for years. McKinsey’s November 2013  iConsumer survey reported a 20 percent decline in email usage […]
Also posted in Marketing, Op-Ed, Patient Communication, social media | Tagged , , | Leave a comment

Pharma M&A: Diverse and Accelerating

By Peter Young. I have been involved with the pharmaceutical and biotech industries, as a strategy consultant with Bain & Company, a venture capitalist with J.H. Whitney, and as an investment banker with Salomon Brothers, Lehman Brothers and Young & Partners. Over that period of time, I have never seen as many different strategies being […]
Posted in Strategy | Leave a comment

BMS and Merck Race to Melanoma Treatment Market

Merck’s Keytruda, recently approved in the US to treat patients with advanced melanoma that have stopped responding to other cancer therapies, will soon face strong competition from Bristol-Myers Squibb’s (BMS) Opdivo,  an analyst from research and consulting firm GlobalData has reported.
Also posted in Europe, Global | Tagged , , , , | Leave a comment

Medical Affairs: From Info Gatekeeper to Value Driver

The role of medical affairs is taking on greater importance, as relationships between life sciences companies and external stakeholders become more complicated. Medical affairs is required to communicate more often with medical practitioners, scientific researchers, patients, patient advocates, and government authorities, and to provide these groups with more complex and more comprehensive information. Unfortunately, many […]
Posted in Strategy | Tagged , | Leave a comment
  • Categories

  • Meta